Search

everythinglearnresearchcommunity

for

Search:↓

Achieving 80% or more scalp hair regrowth is considered a successful treatment for significant hair loss.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Alopecia areata severity in children is linked to atopy history, disease duration, and nail involvement, but not anemia.

Alopecia areata severity and symptoms vary by race and ethnicity.

Alopecia areata severity and child's age greatly affect the quality of life for children and their parents.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Individualized Homeopathic Medicine shows promise for treating alopecia with lasting hair regrowth.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Vitamin D may help reduce severity and relapse of alopecia areata.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Deucravacitinib helped a man regrow hair significantly.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

The document suggests using a topical Vitamin D treatment for hair loss rather than oral supplements and calls for more research.

Trichoscopy helps diagnose and assess the severity of two types of hair loss diseases, androgenetic alopecia and alopecia areata.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Changes in skin bacteria may relate to alopecia areata severity.

No link between scalp patterns and alopecia severity in children, but more severe cases often had nail abnormalities.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Certain gene variations may increase the risk and severity of alopecia areata.

Enterococcus faecalis may be linked to the severity of alopecia areata.